Durasphere Post-Approval Studies Should Focus On Subgroups - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Advanced UroScience is anticipating a worldwide launch of the injectable bulking agent Durasphere sometime in the fourth quarter, following an approvable recommendation from FDA's Gastroenterology and Urology Devices Panel at its July 29 meeting in Rockville, Maryland.